[HTML][HTML] Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD

F Lavorini, A Magnan, JC Dubus, T Voshaar… - Respiratory …, 2008 - Elsevier
BACKGROUND: Incorrect usage of inhaler devices might have a major influence on the
clinical effectiveness of the delivered drug. This issue is poorly addressed in management …

Colistin: an update on the antibiotic of the 21st century

S Biswas, JM Brunel, JC Dubus… - Expert review of anti …, 2012 - Taylor & Francis
The emergence of multidrug-resistant Gram-negative bacteria that cause nosocomial infections
is a growing problem worldwide. Colistin was first introduced in 1952 and was used until …

[HTML][HTML] Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients

F Bittar, H Richet, JC Dubus, M Reynaud-Gaubert… - PloS one, 2008 - journals.plos.org
Background There is strong evidence that culture-based methods detect only a small proportion
of bacteria present in the respiratory tracts of cystic fibrosis (CF) patients. Methodology/…

Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey

…, M Fayon, J Brouard, JC Dubus… - European …, 2013 - Eur Respiratory Soc
Omalizumab has been shown to reduce exacerbation rates in moderate to severe allergic
asthma. Our aim was to evaluate omalizumab efficacy and safety in a real-life setting in severe …

Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden

…, J Brouard, P Cros, C De Lira, JC Dubus… - The Journal of Allergy …, 2020 - Elsevier
Background It is unclear whether asthma may affect susceptibility or severity of coronavirus
disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have …

[HTML][HTML] A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

…, G Brinchault, E Coirier-Duet, JC Dubus… - Journal of cystic …, 2020 - Elsevier
Abstract Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2,
on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in …

Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients

…, O Brocq, D Chan, R Dagher, JC Dubus… - The Journal of Allergy …, 2021 - Elsevier
Background Gain-of-function mutations in STING1 underlie a type I interferonopathy termed
SAVI (STING-associated vasculopathy with onset in infancy). This severe disease is variably …

[HTML][HTML] The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

…, G Brinchault, E Coirier-Duet, JC Dubus… - Journal of cystic …, 2020 - Elsevier
With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …

Real-life long-term omalizumab therapy in children with severe allergic asthma

…, M Fayon, J Brouard, JC Dubus… - European …, 2015 - Eur Respiratory Soc
We previously reported the French real-life experience of 1 year of add-on treatment with
omalizumab in 101 severe allergic asthmatic children (6–18 years), 92 of whom were still …

Childhood asthma outcomes during the COVID‐19 pandemic: findings from the PeARL multi‐national cohort

…, JA Castro‐Rodriguez, Z Chen, P Cros, JC Dubus… - Allergy, 2021 - Wiley Online Library
Background The interplay between COVID‐19 pandemic and asthma in children is still
unclear. We evaluated the impact of COVID‐19 pandemic on childhood asthma outcomes. …